Savara to present at two upcoming healthcare conferences

Langhorne, pa.--(business wire)--savara inc. (nasdaq: svra), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that its management team will be participating at the following investor healthcare conferences: guggenheim 6th annual biotechnology conference february 7, 2024 at 8:30am pt/ 11:30am et fireside chat st. regis hotel, new york city, ny oppenheimer 34th annual healthcare life sciences conference february 13, 2024 at 7:40am pt / 10:40am et co.
SVRA Ratings Summary
SVRA Quant Ranking